Company intelligence / Profile preview

Lenoss Medical

Providence, Rhode Island, United Stateslenoss.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lenoss Medical has developed the first fully biologic, cementless technology intended to immediately stabilize damaged vertebrae by leveraging the natural healing properties of healthy bone. The company’s lead product, the OsteoPearl VBA System, aims to provide a physiological treatment pathway for osteoporotic spinal column fractures. No published clinical trial results are available as of June 2025, but the company has raised seed funding and is advancing toward broader commercialization.

Therapeutic areas: Rheumatology
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Drug pipeline

1 asset

OsteoPearl VBA System

Commercial

Indications: Vertebral compression fractures, Osteoporosis

Beyond the preview

Go deeper on Lenoss Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lenoss Medical.

Explore the full profile